Table 2 Univariate logistic regression analysis of predictors for tumor response
Predictors | OR (95% CI) | P |
|---|---|---|
Age (years) | ||
≥ 60 vs. < 60 | 1.28 (0.38–4.22) | 0.691 |
Sex | ||
Male vs. female | 0.81 (0.25–2.59) | 0.721 |
Smoking history | ||
Smoker vs. never smoker | 0.47 (0.15–1.45) | 0.189 |
Performance status | ||
1 vs. 0 | 0.72 (0.24–2.19) | 0.568 |
Histological types | ||
AD vs. SCC | 1.50 (0.49–4.54) | 0.437 |
Metastatic status | ||
Multiple vs. isolated | 2.13 (0.63–7.16) | 0.223 |
Size of targeted lung metastases | ||
> 3 cm vs. ≤ 3 cm | 1.49 (0.48–4.68) | 0.491 |
Primary T stage | ||
T2–4 vs. T1 | 0.87 (0.26–2.94) | 0.818 |
Primary N stage | ||
N1–3 vs. N0 | 1.43 (0.40–5.13) | 0.580 |
Primary AJCC stage | ||
III vs. I–II | 2.17 (0.43–10.98) | 0.349 |
BED10 | ||
High vs. low | 0.31 (0.09–1.02) | 0.055 |
Naive CD4+ T | ||
High vs. low | 16.25 (3.17–83.13) | 0.001 |
Memory CD4+ T | ||
High vs. low | 0.14 (0.04–0.50) | 0.003 |
Naive CD8+ T | ||
High vs. low | 4.87 (0.97–24.37) | 0.054 |
Memory CD8+ T | ||
High vs. low | 0.11 (0.01–0.87) | 0.037 |
CD4+ naive/memory ratio | ||
High vs. low | 11.27 (2.67–47.58) | 0.001 |
CD8+ naive/memory ratio | ||
High vs. low | 4.00 (0.98–16.26) | 0.053 |